WallStreetZenWallStreetZen

NASDAQ: RGC
Regencell Bioscience Holdings Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Regencell Bioscience Holdings earnings were -$4.3M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest RGC earnings report on Jun 30, 2024 announced Q2 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, RGC reported annual earnings of -$4.3M, with -26.7% growth.

RGC earnings history

Current Revenue
$0.0
Current Earnings
-$4.3M
Current Profit Margin
0%

RGC Return on Equity

Current Company
-42.5%
Current Industry
10.2%
Current Market
33.7%
RGC's Return on Equity (-42.5%)... subscribe to Premium to read more.
High Return on Equity Performance

RGC undefined

Current Company
-40.9%
Current Industry
3.6%
RGC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RGC announces earnings.

RGC undefined

Current Company
-52.18%
Current Industry
10.9%
RGC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RGC vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RGC-$3.56M-$4.30MN/A-$0.33
AVDL-$35.57M-$48.83MN/A-$0.51
EOLS-$25.00M-$50.42MN/A-$0.81
CRON-$5.04M$41.08MN/AN/A
PAHC$98.71M$19.32M-12.39%$0.48
View Top Pharmaceutical Stocks

Regencell Bioscience Holdings Earnings Reports & History FAQ

What were Regencell Bioscience Holdings's earnings last quarter?

Regencell Bioscience Holdings (NASDAQ: RGC) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total RGC earnings for the quarter were N/A. In the same quarter last year, Regencell Bioscience Holdings's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Regencell Bioscience Holdings stock.

Is Regencell Bioscience Holdings profitable or losing money?

As of the last Regencell Bioscience Holdings earnings report, Regencell Bioscience Holdings is currently losing money. Regencell Bioscience Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$4.30 million, a 26.73% decrease year over year.

What was RGC's earnings growth in the past year?

As of Regencell Bioscience Holdings's earnings date in Q1 2025, Regencell Bioscience Holdings's earnings has grown year over year. RGC earnings in the past year totalled -$4.30 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.